Skip to main content
. 2020 Feb 7;8:30. doi: 10.3389/fped.2020.00030

Table 4.

Rodent models of neonatal pain with subsequent pain and time of assessments.

“2-Hit” Models
1st Stimulus (age) Basal outcome measure(s) Age/Time 2nd Stimulus (age) Outcome measure(s) Age/Time References
INFLAMMATORY + INFLAMMATORY PAIN
CFA
(P0 or 14)
Capsaicin (P56–84) Pain behavior
PWT
PWL
Paw diameter
SC [c-Fos]
5 min
5, 15, 30, 45, 60 min
5, 15, 30, 45 min
60 min
(195)
CFA
(P1 or 14)
CFA (P84) PWL P85 (193)
CFA
(PO)
PWT, PWL P56 CFA (P56) PWT, PWL P57 (194)
CFA
(P0, 1, 3, or 14)
PWL P56–70 CFA (P56–70) PWL 24 h (134)
CFA
(P0, 1, 3, or 14)
PWL P56–70 Formalin (P56–70) Pain behavior Every 5 min for 60 min (134)
CAR
(P0, 1, 3, 5, 8, 10, 12, or 14)
PWT, PWL P40 CFA (P40) PWT, PWL P41 (135)
CAR
(P3)
CFA (P6, 13, 24, 40, or 62) PWT 24 h (135)
CAR
(P3)
PWT, PWL P120–125 CFA (P120–125) PWT, PWL 24 h (135)
CAR
(P0 or P14)
PWL, Pain behavior 3, 6, 12, 18, 24, 48, 60 h, and P60 CFA (P61) PWT, PWL, paw diameter P62 (198)
CAR
(P0)
PWL, tail flick P40, 60 CFA (P60) PWL, paw diameter 1, 7, 14, 21 (196)
CAR
(P0, 8, or 14)
PWL, paw diameter P40, 60 CFA (P60) PWL P61 (197)
CAR
(P3)
PWL P48, 49 CFA (P50) PWL, tail flick, electrophysiology 24 h (145)
CAR
(P3 or 14)
Mustard oil (Colon) (P60–70) PWL, visceromotor response 0, 30, 90, 150, 210 min (199)
Formalin
(P1–2 or 7–8)
PWL P25 Picric acid + maternal deprivation (P25) Pain behavior PWL 1–20 min P26 (96)
Formalin
(P7–8)
Formalin (P25) EPM, FST, MWM, nociceptive activity P25–38 (200)
INFLAMMATORY PAIN + STRESS
CAR
(P0)
Chronic stress (P82–109) MWM P94–117, 144–162, 424–442 (61)
CAR
(PO)
Chronic stress (P85–P105) FST 7 days (210)
INFLAMMATORY + TISSUE-BREAKING PAIN
CFA
(P1)
PWT P35, 42, 49 Incision (P50) PWT 4 h, 1, 2, 3, 4, 7 d (171)
INFLAMMATORY + NERVE INJURY
CFA
(P0, 1, 3, or 14)
Sciatic nerve injection (P56–84) SC [WGA-HRP density] 48 h (134)
CFA
(PO)
PWT, PWL P56 SNL (P56) PWT, PWL P57, 60, 63, 70, 77, 84 (194)
CFA
(tail) (P3)
PWT, PWL P56 TNI (P56) PWT, PWL P57, 60, 63, 70, 77, 84 (194)
SNI
(P10)
SC [IBA1] 6, 24, 72 h LPS (P10–19, 19–21) PWT 0, 30, 60, 90, 120, 150 min (201)
TISSUE-BREAKING + INFLAMMATION/OTHER PAIN
RNP
(P0–7)
CFA (P56) PWT P57 (202)
RNP
(P2–8)
PWL P14–16, 35–36, 64–66 Formalin (P14–16, 35–37, or 64–66) Pain behavior 2–7 days (203)
TISSUE-BREAKING + TISSUE-BREAKING PAIN
RNP
(P0–7)
PWT

PWL
1, 3, 5 h (P0–7), Weekly, P21–56
Weekly, P21–56
Incision (P56) PWT
SC [CGRP, VGLUT2]
1, 3, 4, 7, 9, 11 days (37)
RNP
(P0–7)
PWT 1, 3, 5 h (P0–7) Incision (P42–56) Electrophysiology P42–56 (98)
RNP
(P0–7)
PWT 1, 3, 5 h (P0–7), Weekly P21–56 Incision (P56) PWT 1, 3, 5, 7, 9 days (204)
RNP
(P0–7)
PWT
PWT, PWL
1, 3, 5 h (P0–7) Weekly P21–56 Incision (P56) PWT, PWL 1, 3, 5, 7, 9 days (214)
RNP
(P2–14)
Acute stress (P15 or 20–21) ACTH, corticosterone 5, 30, 60, or 90 min (205)
Incision
(P3, 6, 10, 21 or 40)
PWT 0, 4, 24, 48, 72 h Incision (P17, 20, 24, 35, or 54) PWT

EMG
0, 4, 24, 48, 72 h, and 7 days
24 h
(100)
Incision
(P3)
Incision (P56) PWT, PWL, IBA1, EMG 0, 1, 3, 5, 7, 10, 14, 19, 21, 28 days (16)
Incision
(P3, 10, 17)
Incision (P90) PWT, PWL, OFA, brain [c-Fos], novelty-induced hyponeophagia 0, 1, 2, 5 days (97)
Incision
(P3)
PWT 3, 4, 24 h Incision (P42–49) PWT, PWL

EMG
CPP, NOR
0, 1, 2, 4, 7, 9, 12, 17, 21 days
0, 24 h
24 h
(207)
Incision
(P3)
PWT
EMG
SC [IBA1]
3, 4, 24, 48, 72 h
6 h
24 h
Incision (P42) PWT, PWL

EMG, OFA
SC [IBA1]
0, 1, 2, 3, 7, 10, 14, 17, 21 days
24 h
P6
(206)
Incision
(P3)
Incision (P70) PWT, PWL, inclined plate test
SC [IBA1]
Electrophysiology
0, 1, 3, 5, 7, 14, 21 days
0, 1, 3, 5 7 days
7 days
(163)
OTHER PAIN + OTHER PAIN
Orogastric suctioning
(P2–11)
PWL P60 Colorectal distention (P60) PWL, visceral sensitivity 24 h (209)
Lesion to motor cortex
(P7)
Lesion to motor cortex (P70) SC histology P70 (208)
Electrical stimulation
(P10)
Electrical stimulation ± Capsaicin (adult; not specified) PWT
SC [IBA1]
0, 3, 24, 48 h
48 h
(164)

P, post-natal day; CFA, complete Freud's' adjuvant; CAR, carrageenan; RNP; repetitive needle prick; SNI, spared nerve injury; CCI, chronic constriction injury; PWT, paw withdrawal threshold; PWL, paw withdrawal latency; IC, incapacitance meter; SC, spinal cord; DRG, dorsal root ganglion; IBA1, immunostaining for ionized calcium-binding adapter molecule 1 (microglia marker); c-Fos, proto-oncogene; CGRP, calcitonin gene-related peptide; ATF3, Activating transcription factor 3; IB4, isolectin B4; NF200, Neurofilaments protein; GFAP, glial fibrillary acidic protein; BDNF, Brain-derived neurotrophic factor; WB, western blot; ACTH, adrenocorticotropic hormone; EPM, elevated plus maze; OFA, open field arena; MWM, Morris water maze; CPP, conditioned place preference; FST, forced swim test; EMG, electromyography; NOR, novel object recognition.